Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06598202 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

Study acronym: de-ALS
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 31, 2024 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Sep 9, 2024 to Dec 1, 2024
    • Primary and study completion dates: Feb 28, 2026 to May 30, 2026
    • Secondary endpoints: details revised at 9 of 10 entries
    • Study description shortened, about 12 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Xuanwu Hospital, Beijing
204 trials monitored
See 3 trials at risk
ALS
398 trials monitored
See 21 trials at risk
This is a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of nasal drop exosomes derived from human umbilical cord blood mesenchymal stem cells (hUC-MSC-sEV-001) in amyotrophic lateral sclerosis.
Trial Details
NCT Number NCT06598202
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Shengqi Medical Technology (Guangzhou) Co., Ltd., Viyun (Xiamen) Biomedical Research Institute Co., Ltd.
Conditions
(from sponsor)		 Amyotrophic Lateral Sclerosis
Related terms Amyotrophic Lateral Sclerosis, Inflammation, Neurodegenerative Diseases
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov